Profund Advisors
PGEN icon

Profund Advisors’s Precigen PGEN Stock Holding History

Profund Advisors’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$747K Sell
87,249
-12,554
-13% -$82.3K 0.02% 455
2026
Q2 		$569K Sell
99,803
-42,559
-30% -$184K 0.02% 517
2026
Q1 		$551K Buy
142,362
+3,955
+3% +$16.2K 0.02% 519
2025
Q4 		$579K Buy
138,407
+114,454
+478% +$443K 0.02% 506
2025
Q3 		$78.8K Buy
+23,953
New +$67.6K ﹤0.01% 1041
2019
Q3 		– Sell
-18,840
Closed -$144K – 1318
2019
Q2 		$144K Sell
18,840
-2,379
-11% -$12.8K 0.01% 1171
2019
Q1 		$112K Buy
21,219
+32
+0.2% +$222 0.01% 1182
2018
Q4 		$139K Sell
21,187
-5,377
-20% -$60.3K 0.01% 1068
2018
Q3 		$457K Buy
26,564
+3,455
+15% +$51.4K 0.02% 893
2018
Q2 		$322K Buy
23,109
+1,101
+5% +$18.6K 0.01% 1113
2018
Q1 		$337K Sell
22,008
-999
-4% -$14.3K 0.01% 1063
2017
Q4 		$265K Sell
23,007
-2,859
-11% -$42.6K 0.01% 1209
2017
Q3 		$492K Buy
25,866
+2,516
+11% +$51.8K 0.02% 768
2017
Q2 		$563K Sell
23,350
-1,270
-5% -$27.8K 0.03% 662
2017
Q1 		$488K Sell
24,620
-2,289
-9% -$51.1K 0.02% 867
2016
Q4 		$648K Sell
26,909
-4,310
-14% -$120K 0.03% 726
2016
Q3 		$867K Buy
31,219
+3,563
+13% +$94.2K 0.04% 453
2016
Q2 		$675K Sell
27,656
-837
-3% -$23.7K 0.03% 600
2016
Q1 		$957K Sell
28,493
-6,941
-20% -$219K 0.05% 365
2015
Q4 		$1.06M Buy
35,434
+329
+0.9% +$11.1K 0.05% 337
2015
Q3 		$1.11M Buy
+35,105
New +$1.71M 0.06% 260

Other funds holding PGEN

Patient Capital Management
Patient Capital Management Baltimore, Maryland $3.15B AUM 29.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Iridian Asset Management
Iridian Asset Management Westport, Connecticut $275M AUM 37.66% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 38.25% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Profund Advisors's PGEN Position: Q3 2026 in Review

Profund Advisors reduced its Precigen (PGEN) stake by 13% in Q3 2026, selling an estimated $82.3K and leaving 87,249 shares worth $747K. The position accounts for 0.02% of the portfolio, ranked #455.

Profund Advisors first reported a position in PGEN in Q3 2015 and has held it in 21 quarters since. The position peaked at $1.11M in Q3 2015. 136 funds tracked by Wall St. Rank hold PGEN as of Q3 2026.

  • Profund Advisors held 87,249 shares of Precigen worth $747K as of Q3 2026.
  • Profund Advisors sold 12,554 Precigen shares in Q3 2026, an estimated $82.3K.
  • Precigen made up 0.02% of Profund Advisors's portfolio in Q3 2026, its #455 holding.
  • Profund Advisors first reported a position in Precigen in Q3 2015 and has held it in 21 quarters since.
  • Profund Advisors's Precigen position peaked at $1.11M in Q3 2015.
  • 136 funds tracked by Wall St. Rank held Precigen as of Q3 2026.

Based on Profund Advisors's 13F filing for Q3 2026, filed 29 Oct 2026.